Heterooligomerization has been observed between TRIM27 and TRIM19 with the recruitment of the former to promyelocytic leukaemia nuclear bodies (PMLs) [32].
Interaction with members of the protein inhibitors of activated STAT (PIAS) family results in targeting of TRIM27 to subnuclear compartments by TRIM27 SUMOylation [33].